Drug of Choice
ISBN-10:
150121652X
ISBN-13:
9781501216527
Author(s): Lange, John; CRICHTON,MICHAEL
Edition: Unabridged
Description:
On a secret island in the Caribbean, bioengineers have devised a vacation resort like no other, promising the ultimate escape. But when Dr. Roger Clark investigates, he discovers the dark secret of Eden Island and of Advance Biosystems, the shadowy corporation underwriting it.…
Best prices to buy, sell, or rent ISBN 9781501216527
Related Books
- 1
- 2
- 3
- 4
- Drug of Choice (Hard Case Crime)Lange, John; CRICHTON,MICHAELEdition:F Later EditionISBN-13:9781783291236
- Drug of ChoiceMichael Crichton as John LangeEdition:First EditionISBN-13:9780451041166
- Drug of ChoiceLange, John; CRICHTON,MICHAELEdition:UnabridgedISBN-13:9781501216503
- Drug of ChoiceLange, John; CRICHTON,MICHAELEdition:UnabridgedISBN-13:9781501262272
- Drug of Choice (Hard Case Crime)Lange, John; CRICHTON,MICHAELEdition:F Later EditionISBN-13:9781783291236
- Drug of ChoiceMichael Crichton as John LangeEdition:First EditionISBN-13:9780451041166
Drug of Choice
Michael Crichton as John Lange
Edition:First Edition
ISBN-13:9780451041166
Drug of Choice
Lange, John; CRICHTON,MICHAEL
Edition:Unabridged
ISBN-13:9781501216503
Drug of Choice
Lange, John; CRICHTON,MICHAEL
Edition:Unabridged
ISBN-13:9781501262272
Drug of Choice (Hard Case Crime)
Lange, John; CRICHTON,MICHAEL
Edition:F Later Edition
ISBN-13:9781783291236
Frequently Asked Questions about Drug of Choice
You can buy the Drug of Choice book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .
If you’re interested in selling back the Drug of Choice book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Drug of Choice book, the best buyback offer comes from and is $ for the book in good condition.
Not enough insights yet.
Not enough insights yet.